InsidersTradesSigma
申报总数
公司
▲ 买入（6 笔）
▼ 卖出（6 笔）
内部人交易记录
董事已披露买入
6
已披露卖出
6
T+90 胜率
25%
T+90 平均收益
-4.8%
基于 4 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Discover the complete record of transactions filed by Fairbairn Robert W, 董事. Officer active across 9 companies, notably BlackRock Innovation & Growth Trust. In total, 14 filings have been recorded. Breakdown: 6 buys · 6 sells. Total volume traded: €2.4m. History available since 22 November 2021. The latest transaction was disclosed on 27 February 2026 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Fairbairn Robert W
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报14 总计
49,025 股@ US$10.1492100.0% 占其流量Common StockSEC:0001193125-26-087911:0
标准退出：2026年5月28日 (T+90)
10,294 股@ US$14.98100.0% 占其流量Common StockSEC:0001193125-25-329003:0
21,936 股@ US$6.52100.0% 占其流量Common StockSEC:0001193125-25-328969:0
9,293 股@ US$22.51100.0% 占其流量Common StockSEC:0001193125-25-328961:0
41,380 股@ US$14.488975.1% 占其流量Common StockSEC:0000899243-22-017976:0
标准退出：2022年8月9日 (T+90)
6,835 股@ US$36.33250.011% mcap50.0% 占其流量Common StockSEC:0000899243-22-005453:0
标准退出：2021年3月29日 (T+90)
12,500 股@ US$17.062224.9% 占其流量Common StockSEC:0000899243-22-003538:0
标准退出：2022年4月26日 (T+90)
15,900 股@ US$12.907899.0% 占其流量Common StockSEC:0000899243-22-003539:0
标准退出：2022年4月26日 (T+90)
101 股@ US$19.770.4% 占其流量Common StockSEC:0000899243-21-046022:0
21,141 股@ US$22.979199.6% 占其流量Common StockSEC:0000899243-21-046016:0
标准退出：2021年3月18日 (T+90)
128 股@ US$16.7351.0% 占其流量Common StockSEC:0000899243-21-046020:0
5,000 股Shares Of Common Stock (par Value $0.01 Per Share)SEC:0001127602-16-041419:0
14,480 股Shares Of Common Stock (par Value $0.01 Per Share)SEC:0001127602-16-039316:0
3,545 股Shares Of Common Stock (par Value $0.01 Per Share)SEC:0001127602-16-037542:0
14 条申报中的 14 条
About Fairbairn Robert W
Fairbairn Robert W is an Administrateur and a declarant linked to BlackRock Inc., where he is Senior Managing Director, as well as to BlackRock ESG Capital Allocation Trust, BlackRock Innovation & Growth Trust, BlackRock Capital Allocation Trust, Blackrock Muniyield NEW York Quality Fund, INC. and BlackRock Health Sciences Term Trust, where he is Director. Across 14 filings, the sampled recent filings cover the period from 2016-01-21 to 2026-03-03, with 1961417 in buys and 434941 in sells, and the modal transaction nature is Acquisition.
